Start by looking at the culture itself; the values, unconscious messages, and behaviours of leaders and employees.
Align with the way people actually relate to one another and to the organisation.
Innovation needs time to develop. No one ever feels like they have time to spare, not everyone feels like an innovator.
Encourage your employees to ask themselves—
- What is the essential purpose of my role?
- What is the outcome that I deliver that is of real value to my patients?
- Is there a better way to deliver that value or purpose?
Making time to experiment with new technologies, ideas, or processes can create a breakthrough. Just enough structure and support is required to help people navigate uncertainty and tap into the creative process without stifling it.
Informal recognition is powerful, as it shapes organisational values. Informal acknowledgments encourage a collective spirit and promote the free flow of ideas.
Make it easy and rewarding for the people whose roles and actions influence the developing innovation culture.
Innovation is an increasingly important part of healthcare delivery. Demand is from both health delivery management and for staff retention. There are three primary goals driving this change –
- lowering cost
- improving outcomes
- and increasing access.
We can assist you to define and value your idea, consider potential pathways for development and provide key connections or introductions.
Innovation Hubs Around the World
Initiatives in Health innovation are increasingly common around the world. Ireland has launched a Health Innovation Hub Ireland Health Innovation Hub Canada has MARS EXCITE Toronto a tertiary/hospital/local government partnership.
Current Research and Development Trends
Further exploration of the gut immune response and how it can influence the development of inflammatory diseases. Presents new opportunities for targeting and treating inflammatory diseases.
Wearable sensors can remotely monitor vital statistics. Smart phones have enabled rapid development. However there is much uncertainty around regulation of mobile health. Measuring the efficacy of the data from the app and whether the results are reliable are yet to come. Concerns exist regarding ownership of data as most countries have privacy laws protecting patients’ data.
Research into the human genome is ongoing and has produced interesting results that are being used in medicine to help to identify health risks, susceptibility to diseases and how a patient will respond to certain pharmaceuticals.
Genomic research is useful in the treatment of cancer, enabling comparison with the abnormal genetic structure of a tumour with that of a patient, oncologists can discern which mutations have occurred and target their chemotherapy directly.
The availability of large sets of data (Big Data) is growing. The data is produced from EHRs, lab and imaging systems, clinician notes, and medical correspondence. Access to this data and using it for clinical and advanced analytics is critical to improving care and outcomes, driving the right behaviour and efficiencies.
It can also be used to engage and educate consumers to make better decisions about preventative care that can improve health and reduce demand and waste in healthcare.